Evidence for modulated immune response to Anaplasma phagocytophila sensu lato in cats with FIV-induced immunosuppression

Comparative Immunology, Microbiology and Infectious Diseases

Volumn 26, Issue 2, 2003, Pages 103-113

  Foley, J E ^a   Leutenegger, C M ^a   Dumler, Stephen J ^b   Pedersen, N C ^a   Madigan, J E ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Acquired immune deficiency syndrome; Anaplasma phagocytophila; Feline immunodeficiency virus; Human granulocytic ehrlichiosis

Indexed keywords

ANTINUCLEAR ANTIBODY; GAMMA INTERFERON; INTERLEUKIN 10; MESSENGER RNA; VIRUS VACCINE;

ANAPLASMA; ANIMAL CELL; ATTENUATION; CAT DISEASE; CONTROLLED STUDY; DISEASE MODEL; DISEASE SEVERITY; DRUG RESPONSE; EHRLICHIOSIS; FELINE IMMUNODEFICIENCY VIRUS; GENETIC TRANSCRIPTION; HEALTH STATUS; IMMUNE DEFICIENCY; IMMUNE RESPONSE; IMMUNOMODULATION; NONHUMAN; REVIEW; VIRUS IMMUNITY; VIRUS PATHOGENESIS;

ANAPLASMA; ANAPLASMA PHAGOCYTOPHILUM; FELIDAE; FELINE IMMUNODEFICIENCY VIRUS; FELIS CATUS;

EID: 0037367916     PISSN: 01479571     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0147-9571(02)00023-1     Document Type: Article

References (48)

1. Dumler JS, Bakken JS. Human ehrlichioses: newly recognized infections transmitted by ticks. Annu Rev Med 1998;49:201-13.
2. Dumler J, Bakken J. Ehrlichial diseases of humans: emerging tick-borne infections. Clin Infect Dis 1995;20:1102-5.
3. Reubel GH, Dean GA, George JW, Barlough JE, Pedersen NC. Effects of incidental infections and immune activation on disease progression in experimentally feline immunodeficiency virus-infected cats. J Acquir Immune Defic Syndr 1994;7:1003-15.
4. Barlough J, Madigan J, DeRock E. Protection against Ehrlichia equi is conferred by prior infection with the human granulocytic ehrlichia (HGE agent). J Clin Microbiol 1995;33: 3333-4.
5. Dean GA, Quackenbush SL, Ackley CD, Cooper MD, Hoover EA. Flow cytometric analysis of T-lymphocyte subsets in cats. Vet Immunol Immunopathol 1991;28:327-35.
6. Barlough J, Madigan J, DeRock E, Bigornia L. Nested polymerase chain reaction for detection of Ehrlichia equi genomic DNA in horses and ticks (Ixodes pacificus). Vet Parasitol 1996;63: 319-29.
7. Leutenegger CM, Mislin CN, Sigrist B, Ehrengruber MU, Hofmann-Lehmann R, Lutz H. Quantitative real-time PCR for the measurement of feline cytokine mRNA. Vet Immunol Immunopathol 1999;71:291-305.
8. Dean GA, Bernales JA, Pedersen NC. Effect of feline immunodeficiency virus on cytokine response to Listeria monocytogenes in vivo. Vet Immunol Immunopathol 1998;65:125-38.
9. Lappin MR, Marks A, Greene CE, Rose BJ, Gasper PW, Powell CC, Reif JS. Effect of feline immunodeficiency virus infection on Toxoplasma gondii-specific humoral and cell-mediated immune responses of cats with serologic evidence of toxoplasmosis. J Vet Intern Med 1993;7: 95-100.
10. Lappin MR, George JW, Pedersen NC, Barlough JE, Murphy CJ, Morse LS. Primary and secondary Toxoplasma gondii infection in normal and feline immunodeficiency virus-infected cats. J Parasitol 1996;82:733-42.
11. Pedersen N, Ho E, Brown M, Yamamoto J. Isolation of a T-lymphotropic virus from domestic cats with an immunodeficiency-like syndrome. Science 1987;235:790-3.
12. Yamamoto JK, Hansen H, Ho EW, Morishita TY, Okuda T, Sawa TR, Nakamura RM, Pedersen NC. Epidemiologic and clinical aspects of feline immunodeficiency virus infection in cats from the continental United States and Canada and possible mode of transmission. J Am Vet Med Assoc 1989;194:213-20.
13. Dua N, Reubel G, Moore PF, Higgins J, Pedersen NC. An experimental study of primary feline immunodeficiency virus infection in cats and a historical comparison to acute simian and human immunodeficiency virus diseases. Vet Immunol Immunopathol 1994;43:337-55.
14. Ackley CD, Yamamoto JK, Levy N, Pedersen NC, Cooper MD. Immunologic abnormalities in pathogen-free cats experimentally infected with feline immunodeficiency virus. J Virol 1990; 64:5652-5.
15. Barlough J, Ackley C, George J, Levy N, Acevedo J, Moore PF, Rideout BA, Cooper MD, Pedersen NC. Acquired immune dysfunction in cats with experimentally induced feline immunodeficiency virus infection: comparison of short-term and long-term infections. J Acquir Immunodefic Syndr 1991;4:219-27.
16. Charpentier G. Un cas d'ehrlichiose probable chez le chat. B Acad Vet Fr 1986;59:287-90.
17. Beaufils J, Martin-Granel J, Jumelle P. Infection du chat par une Ehrlichia sp.: a propos de trois cas. Pract Med Chirurgical Anim Compagn 1995;30:397-402.
18. Buoro IB, Atwell RB, Kiptoon JC, Ihiga MA. Feline anaemia associated with Ehrlichia-like bodies in three domestic short-haired cats. Vet Rec 1989;125:434-6.
19. Bouloy R, Lappin M, Holland C, Thrall M, Baker D, O'Neil S. Clinical ehrlichiosis in a cat. J Am Vet Med Assoc 1994;204:1475-8.
20. Bjöersdorff A, Svendenius L, Owens JH, Massung RF. Feline granulocytic ehrlichiosis - a report of a new clinical entity and characterisation of the infectious agent. J Small Anim Pract 1999;40:20-4.
21. Lewis G, Huxsoll D, Ristic M, Johnson A. Experimentally induced infection of dogs, cats, and nonhuman primates with Ehrlichia equi, etiologic agent of equine ehrlichiosis. Am J Vet Res 1975;36:85-8.
22. Madewell B, Gribble D. Infection in two dogs with an agent resembling Ehrlichia equi. J Am Vet Med Assoc 1982;180:512-4.
23. Foley JE, Lerche NW, Dumler JS, Madigan JE. A simian model of human granulocytic ehrlichiosis. Am J Trop Med Hyg 1999;60:987-93.
24. Yoshiie K, Kim HY, Mott J, Rikihisa Y. Intracellular infection by the human granulocytic ehrlichiosis agent inhibits human neutrophil apoptosis. Infect Immunity 2000;68:1125-33.
25. Bakken J, Dumler J, Chen S, Eckman M, Van Etta L, Walker D. Human granulocytic ehrlichiosis in the upper midwest United States. A new species emerging? J Am Med Assoc 1994;272:212-8.
26. Hardalo C, Quagliarello V, Dumler J. Human granulocytic ehrlichiosis in Connecticut: report of a fatal case. Clin Infect Dis 1995;21:910-4.
27. Adachi J, Grimm E, Johnson P, Uthman M, Kaplan B, Rakita R. Human granulocytic ehrlichiosis in a renal transplant patient. Transplantation 1997;64:1139-42.
28. Gewirtz A, Cornbleet P, Vugia D, Traver C, Niederhuber J, Kolbert CP, Persing DH. Human granulocytic ehrlichiosis: report of a case in northern California. Clin Infect Dis 1996;23: 653-4.
29. Bunnell JE, Trigiani ER, Srinivas SR, Dumler JS. Development and distribution of pathologic lesions are related to immune status and tissue deposition of human granulocytic ehrlichiosis agent-infected cells in a murine model system. J Infect Dis 1999;180:546-50.
30. Hodzic E, Ijdo J, Feng S, Katavalos P, Sun W, Maretzki CH, Fish D, Fikrig E, Telford SR III, Barthold SW. Granulocytic ehrlichiosis in the laboratory mouse. J Infect Dis 1998;177:737-45.
31. Bakken JS, Krueth J, Wilson-Nordskog C, Tilden RL, Asanovich K, Dumler JS. Clinical and laboratory characteristics of human granulocytic ehrlichiosis. J Am Med Assoc 1996;275:199-205.
32. Foggie A. Further experiments on the effect of tick-borne fever infection on the susceptibility of lambs to Staphylococci. J Comp Pathol 1957;67:369-77.
33. Brodie TA, Holmes PH, Urquhart GM. Some aspects of tick-borne diseases of British sheep. Vet Rec 1986;118:415-8.
34. Gilmour N, Brodie T, Holmes P. Tick-borne fever and pasteurellosis in sheep. Vet Rec 1982; 111:512.
35. Munro R, Hunter AR, MacKenzie G, McMartin DA. Pulmonary lesions in sheep following experimental infection by Ehrlichia phagocytophila and Chlamydia psittaci. J Comp Pathol 1982;92:117-29.
36. Batungbacal M, Scott G. Tick-borne fever and concurrent parainfluenza-3 virus infection in sheep. J Comp Pathol 1982;92:415-28.
37. Taylor A, Holman H, Gordon W. Attempts to reproduce the pyaemia associated with tick-bite. Vet Rec 1941;53:339-44.
38. Foster W, Cameron A. Observations on the functional integrity of neutrophil leucocytes infected with tick-borne fever. J Comp Pathol 1970;80:487-91.
39. Larsen H, Qvernes G, Waldeland H, Johansen G. Immunosuppression in sheep experimentally infected with Ehrlichia phagocytophila. Res Vet Sci 1994;56:216-24.
40. Woldehiwet Z. The effects of tick-borne fever on some functions of polymorphonuclear cells of sheep. J Comp Pathol 1987;97:481-5.
41. Batungbacal M, Scott G, Burrells C. The lymphocytopaenia in tick-borne fever. J Comp Pathol 1982;92:403-7.
42. Woldehiwet Z. Depression of lymphocyte response to mitogens in sheep infected with tick-borne fever. J Comp Pathol 1987;97:637-43.
43. Gokce HI, Ross G, Woldehiwet Z. Inhibition of phagosome-lysosome fusion in ovine polymorphonuclear leucocytes by Ehrlichia (Cytoecetes) phagocytophila. J Comp Pathol 1999; 120:369-81.
44. Foley J, Crawford-Miksza L, Dumler J, Glaser C, Chere J-S, Yeh E, Schnurr D, Madigan JE. Two cases of human granulocytic ehrlichiosis in northern California. Clin Infect Dis 1999;29: 388-92.
45. Wong SJ, Thomas JA. Cytoplasmic, nuclear, and platelet autoantibodies in human granulocytic ehrlichiosis patients. J Clin Microbiol 1998;36:1959-63.
46. Dumler JS, Trigiani ER, Bakken JS, Aguero-Rosenfeld ME, Wormser GP. Serum cytokine responses during acute human granulocytic ehrlichiosis. Clin Diagn Lab Immunol 2000;7:6-8.
47. Akkoyunlu M, Fikrig E. Gamma interferon dominates the murine cytokine response to the agent of human granulocytic ehrlichiosis and helps to control the degree of early rickettsemia. Infect Immun 2000;68:1827-33.
48. Martin ME, Bunnell JE, Dumler JS. Pathology, immunohistology, and cytokine responses in early phases of human granulocytic ehrlichiosis in a murine model. J Infect Dis 2000;181: 374-8.